Separation of circulating cancer cells by unique microfluidic chip in colorectal cancer

Oncology Research

Volumn 19, Issue 10-11, 2012, Pages 487-500

  Du, H X ^a   Zhang, Z G ^a   Yang, Z L ^a   Chen, D ^a   Chen, J D ^a   Hu, R J ^a   Wang, Z G ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Circulating tumor cells; Colorectal neoplasms; Microfluidic analytical techniques; Neoplasm metastasis

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; ARTICLE; BIOCHIP; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL SEPARATION; CIRCULATING TUMOR CELL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAGNETIC FIELD; MALE; MICROCHIP ANALYSIS; MICROFLUIDIC CHIP; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH;

EID: 84859720171     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504012X13286534482476     Document Type: Article

References (21)

1. Ashworth, T. R. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust. Med. J. 14:146; 1869.
2. Mocellin, S.; Keilholz, U.; Rossi, C. R.; Nitti, D. Circulating tumor cells: The 'leukemic phase' of solid cancers. Trends Mol. Med. 12:130-139; 2006.
3. Pantel, K.; Brakenhoff, R. H.; Brandt, B. Detection, clinical relevanceand specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8:329-340; 2008.
4. Tsouma, A.; Aggeli, C.; Pissimissis, N.; Lembessis, P.; Zografos, G. N.; Koutsilieris, M. Circulating tumor cells in colorectal cancer: Detection methods and clinical significance. Anticancer Res. 28:3945-3960; 2008.
5. Mostert, B.; Sleijfer, S.; Foekens, J. A.; Gratama, J. W. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev. 35:436-474; 2009.
6. Fehm, T.; Sagalowsky, A.; Clifford, E.; Beitsch, P.; Saboorian, H.; Euhus, D. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res. 8:2073-2084; 2002.
7. Ulmer, A.; Schmidt-Kittler, O.; Fischer, J.; Ellwanger, U.; Rassner, G.; Riethmuller, G. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Clin. Cancer Res. 10:531-537; 2004.
8. Witzig, T. E.; Bossy, B.; Kimlinger, T.; Roche, P. C.; Ingle, J. N.; Grant, C.; John, D.; Vera, J. S.; Douglas, H.; Jose, T. B.; Kenneth, D. B. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin. Cancer Res. 8:1085-1091; 2002.
9. Meropol, N. J. Epidermal growth factor receptor inhibitors in colorectal cancer: It's time to get back on target. J. Clin. Oncol. 23:1791-1793; 2005.
10. Schuster, R.; Max, B.; Mann, B.; Heufelder, K.; Thilo, F.; Grone, J.; Rokos, F.; Buhr, H. J.; Thiel, E.; Keilholz, U. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int. J. Cancer 108:219-227; 2004.
11. Wolfrum, F.; Vogel, I.; Fändrich, F.; Kalthoff, H. Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. Langenbecks Arch. Surg. 390: 430-441; 2005.
12. Hoffmann, K.; Kerner, C.; Wilfert, W.; Mueller, M.; Thiery, J.; Hauss, J. Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients. World J. Gastroenterol. 13: 257-263; 2007.
13. Ishizone, S.; Yamauchi, K.; Kawa, S.; Suzuki, T.; Shimizu, F.; Harada, O.; Sugiyama, A.; Miyagawa, S.; Fukuda, M.; Nakayama, J. Clinical utility of quantitative RT-PCR targeted to a1, 4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. Cancer Sci. 97:119-126; 2006.
14. Mocellin, S.; Keilholz, U.; Rossi, C. R.; Nitti, D. Circulating tumor cells: The "leukemic phase" of solid cancers. Trends Mol. Med. 12:130-139; 2006.
15. Pantel, K.; Brakenhoff, R. H.; Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8:329-340; 2008.
16. Tsouma, A.; Aggeli, C.; Pissimissis, N.; Lembessis, P.; Zografos, G. N.; Koutsilieris, M. Circulating tumor cells in colorectal cancer: Detection methods and clinical significance. Anticancer Res. 28:3945-3960; 2008.
17. Mostert, B.; Sleijfer, S.; Foekens, J. A.; Gratama, J. W. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev. 35:436-474; 2009.
18. Koyanagi, K.; Bilchik, A. J.; Saha, S.; Turner, R. R.; Wiese, D.; McCarter, M.; Shen, P.; Deacon, L.; Elashoff, D.; Hoon, D. S. B. Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial. Clin. Cancer Res. 14:7391-7396; 2008.
19. Nagrath, S.; Sequist, L. V.; Maheswaran, S.; Bell, D. W.; Irimia, D.; Ulkus, L.; Matthew, R. S. Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature 450:1235-1239; 2007.
20. Allard, W. J.; Matera, J.; Miller, M. C.; Repollet, M.; Connelly, M. C.; Rao, C.; Tibbe, A. G. J.; Uhrm, J. W.; Terstappen, L. W. M. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10:6897-6904; 2004.
21. Takeuchi, H.; Kitajima, M.; Kitagawa, Y. Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells. Cancer Sci. 99:441-450; 2008.